Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines
- 1 October 1997
- journal article
- Published by Elsevier in Molecular Medicine Today
- Vol. 3 (10) , 423-428
- https://doi.org/10.1016/s1357-4310(97)01087-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy.The Journal of Experimental Medicine, 1996
- Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.The Journal of Experimental Medicine, 1996
- Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells.The Journal of Experimental Medicine, 1996
- T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.The Journal of Experimental Medicine, 1996
- In Vivo Effects of Interleukin-10 on Contact Hypersensitivity and Delayed-Type Hypersensitivity ReactionsJournal of Investigative Dermatology, 1994
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell ClonesScience, 1991
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991